PFKFB3 and neoplasm: In summary, these studies detail the successful generation of a novel Pfkfb3 inducible knockout mouse and the first evaluation of in vivo effects of homozygous pan-tissue Pfkfb3 gene disruption and also demonstrate that genomic deletion of Pfkfb3 decreases oncogene-driven tumor growth without adverse systemic effects.